Cargando…

MON-109 Identifying Limiting Factors to Weight Loss and Prevention of Comorbidities in a Patient Population with Obesity

Introduction:  Obesity is a disease affecting 1/3 of our patients and is accompanied by numerous comorbidities, including pre-diabetes (preDM) and diabetes (DM).  Cause of obesity is often multifactorial with biochemical, genetic, and environmental factor contribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johns, Allison, Warriner, Amy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550620/ http://dx.doi.org/10.1210/js.2019-MON-109

Ejemplares similares

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

MON-LB100 Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospectiveanalysisof 1,567 Patientswith Obesity With Successful Clinical Weight-Loss Approaches
por: Cadegiani, Flavio, et al.
Publicado: (2020)

MON-590 Presence of Diabetes Diminishes the Ultimate Weight Loss After Bariatric Surgery
por: Luo, Yingying, et al.
Publicado: (2020)

RF24 | PSUN109 Very Low Calorie Ketogenic Diet combined with interval training for preserving muscle mass during weight loss in sarcopenic obesity: a pilot study
por: Camajani, Elisabetta, et al.
Publicado: (2022)

MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020)

MON-583 Identifying Active Duty Military Meal Planning Preferences to Maximize Nutrition Therapy for Obesity
por: Clerc, Philip, et al.
Publicado: (2020)

MON-584 Albuminuria and Obesity - Which Are the Associated Factors?
por: Costa, Cláudia Fernandes, et al.
Publicado: (2020)

MON-LB020 Compound H Causes a Sustained Reduction in Food Intake and Body Weight in Obese Cynomolgus
por: Hinke, Simon, et al.
Publicado: (2019)

MON-LB104 Update on Anti-Obesity Medical Devices
por: Heshmati, Hassan M
Publicado: (2020)

MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg
por: Rubino, Domenica, et al.
Publicado: (2019)

MON-LB107 Treat: A Randomized Controlled Trial Examining the Effects of Time Restricted Eating on Weight Loss and Metabolic Markers
por: Lowe, Dylan A, et al.
Publicado: (2020)

MON-LB105 Resident Obesity Management: Comfort Correlates With Action
por: Hoppenfeld, Mita Shah, et al.
Publicado: (2020)

MON-LB019 Setmelanotide (RM-493) Reduces Food Intake and Rapidly Induces Weight Loss in a Mouse Model of Alström Syndrome
por: Stephenson, Erin, et al.
Publicado: (2019)

MON-594 The Peculiarity of the Gut Microbiota in Patients with Different Phenotypes of Obesity (Pilot Study)
por: Volkova, Natalia, et al.
Publicado: (2020)

SUN-109 PTEN Regulates Differentiation and Proliferation of Aging Preadipocytes
por: Kirstein, Anna, et al.
Publicado: (2019)

MON-104 Defining the Contribution of Weight to the Extent of Metabolic Disease in FPLD: Insights from a Retrospective "Matched" Case-Control Study
por: Koo, Eden, et al.
Publicado: (2019)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

MON-099 Age-Related Differences in Appetite Regulation among Adults with Obesity: More Than Just Hunger and PYY and Ghrelin? Oh My!
por: Iwamoto, Sean, et al.
Publicado: (2019)

MON-LB108 Measurement Of Carotid Intima,hepatic Steatosis And Inflammatory Markers In Obese Children
por: Bazan, Maria Cristina
Publicado: (2020)

MON-593 Single-Dose Effects of Anti-Obesity Drugs on Human Basal Metabolic Rate
por: Israni, Nikita Sanjay, et al.
Publicado: (2020)

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

MON-602 The Efficacy and Safety of Sodium-Glucose Transport Protein 2 (SGLT-2) Inhibitors for Weight Loss Among Individuals Without Diabetes: A Systematic Review and Meta-Analysis
por: Cabrera, Carmen Carina, et al.
Publicado: (2020)

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
por: Huynh, Kim D, et al.
Publicado: (2021)

Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
por: John, Linu M, et al.
Publicado: (2021)

MON-117 The Association of Adipocytokine Concentrations with Obesity and Metabolic Health in a Mexican-American Border Populations
por: Al-Dallal, Reem, et al.
Publicado: (2019)

MON-LB021 Effects of Intranasal Oxytocin on the Fasting Serum Proteome in Healthy Lean and Obese Men
por: Harshman, Stephanie, et al.
Publicado: (2019)

MON-605 Serum CD163, but Not Gal-3, Predicts Response to Liraglutide Therapy in Obese Patients
por: Mat, Arimin, et al.
Publicado: (2020)

Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial
por: Fox, Claudia K, et al.
Publicado: (2021)

MON-LB101 5-Year Data of an Aggressive Pharmacological Approach to Moderate and Morbid Obesity: Is Prevention of Bariatric Surgery Feasible in the Long Run?
por: Cadegiani, Flavio
Publicado: (2020)

MON-106 Prevalence of Abdominal Obesity According to Different Cutoff Points in the Peruvian Population Living at Different Altitudes
por: Pajuelo-Ramirez, Jaime, et al.
Publicado: (2019)

MON-592 The Impact of Bariatric Surgery on the Risk of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients
por: Borges-Canha, Marta, et al.
Publicado: (2020)

MON-603 GPR142 Expression Levels Were Correlated with Plasma Ghrelin Levels and Heights in Morbidly Obese Patients
por: Ueda, Yoko, et al.
Publicado: (2020)

MON-595 Severe Copper Deficiency Post-Bariatric Surgery with Serious Preventable Complications
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

MON-601 Obesity Pharmacotherapy Is Effective in the United States Veterans Affairs Patient Population: A Local and Virtual Cohort Study
por: Pendse, Jay, et al.
Publicado: (2020)

MON-LB103 Hyperactivation of Reward and Cognitive Control Brain Regions in Response to Food Images in Women Compared to Men With Obesity
por: Getachew, Ethiopia D, et al.
Publicado: (2020)

ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
por: Lawrence, Rebecca, et al.
Publicado: (2022)

OR10-3 Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study
por: Andre, Clarissa, et al.
Publicado: (2022)

MON-098 FSH and Body Composition in Older Adults
por: Woods, Gina, et al.
Publicado: (2019)

SAT-109 tiRNA-5 Reflects the Severity of Mitochondrial Oxidative Stress in Nonalcoholic Fatty Liver Disease
por: Yang, Yashuang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kntftv0p7bipu4q24mbgcinocg